Helicobacter pylori factors involved in the development of gastroduodenal mucosal damage and ulceration

被引:23
作者
Figura, N [1 ]
机构
[1] Univ Siena, Inst Internal Med, Policlin Le Scotte, I-53100 Siena, Italy
关键词
H-pylori infection; urease; VacA; CagA; chronic gastritis; peptic ulcer;
D O I
10.1097/00004836-199700001-00025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Many putative virulence determinants of Helicobacter pylori are believed to trigger and worsen the gastroduodenal mucosa damage observed in infected patients. H. pylori urease reacts with the gastric urea and generates ammonia; ammonia combines with water and yields ammonium hydroxide, which is cytotoxic. Ammonia may also inhibit cell proliferation and cause indirect mucosal injury by stimulating neutrophils. Phospholipases may damage the gastric mucosa by degrading phospholipids and generating precursors of ulcerogenic components. Other enzymes, such as protease, neuraminidase, fucosidase, and alcohol dehydrogenase, can contribute to damage of the gastric epithelium by destroying the integrity of mucus or by inducing lipid peroxidation. Infection by vacuolating cytotoxic (VacA(+)) H. pylori strains is considered to constitute increased risk for development of peptic ulcer and gastric cancer. Exploration of the vacA gene structure has shown the existence of strongly toxigenic strains, and has confirmed at the molecular level the increased ulcerogenic potential of VacA(+) H. pylori strains. A pathogenicity island called cag has been recently described in Type I H. pylori strains (VacA(+)/CagA(+)). cag contains the cagA gene (whose expression is associated with toxigenicity) and many genes, some of which are highly homologous to virulence genes of other virulent bacteria, that account for the enhanced pathogenic potential of CagA(+) organisms.
引用
收藏
页码:S149 / S163
页数:15
相关论文
共 134 条
[1]   MOSAICISM IN VACUOLATING CYTOTOXIN ALLELES OF HELICOBACTER-PYLORI - ASSOCIATION OF SPECIFIC VACA TYPES WITH CYTOTOXIN PRODUCTION AND PEPTIC-ULCERATION [J].
ATHERTON, JC ;
CAO, P ;
PEEK, RM ;
TUMMURU, MKR ;
BLASER, MJ ;
COVER, TL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) :17771-17777
[2]   PROTEOLYTIC ACTIVITIES OF HUMAN CAMPYLOBACTER PYLORI AND FERRET GASTRIC CAMPYLOBACTER-LIKE ORGANISM [J].
BAXTER, A ;
CAMPBELL, CJ ;
COX, DM ;
GRINHAM, CJ ;
PENDLEBURY, JE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (01) :1-7
[3]  
Beales I., 1995, Gut, V37, pA37
[4]  
Bechi P, 1996, AM J GASTROENTEROL, V91, P271
[5]  
Behar S, 1996, GASTROENTEROLOGY, V110, pA862
[6]  
BEIL W, GASTROENTEROLOGY S, V110, pA63
[7]   EOSINOPHIL CATIONIC PROTEIN AND PHOSPHOLIPASE-A2 ACTIVITY IN HUMAN GASTRIC-JUICE - WITH EMPHASIS ON HELICOBACTER-PYLORI STATUS AND EFFECTS OF ANTACIDS [J].
BERSTAD, K ;
BERSTAD, A ;
SJODAHL, R ;
WEBERG, R ;
BERSTAD, A .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (12) :1011-1017
[8]   IMMUNOLOGICAL ACTIVITY OF LIPOPOLYSACCHARIDE OF HELICOBACTER-PYLORI ON HUMAN PERIPHERAL MONONUCLEAR BLOOD-CELLS IN COMPARISON TO LIPOPOLYSACCHARIDES OF OTHER INTESTINAL BACTERIA [J].
BIRKHOLZ, S ;
KNIPP, U ;
NIETZKI, C ;
ADAMEK, RJ ;
OPFERKUCH, W .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1993, 6 (04) :317-324
[9]   GASTRIC CAMPYLOBACTER-LIKE ORGANISMS, GASTRITIS, AND PEPTIC-ULCER DISEASE [J].
BLASER, MJ .
GASTROENTEROLOGY, 1987, 93 (02) :371-383
[10]  
Brannstrom J, 1996, GASTROENTEROLOGY, V110, pA871